A REVIEW ON DRUG INDUCED NEPHROTOXICITY

Main Article Content

Dr. K. Atchuta Kumar

Keywords

Nephrotoxicity, Acute renal failure, Chronic renal failure, Biomarkers

Abstract

Drug-induced nephrotoxicity is influenced by various risk factors, such as drug overdose, drug-drug interactions, and drug-related side effects. Given the continued necessity of utilizing some nephrotoxic medications within the clinical context, it is imperative to acquire a comprehensive grasp of the pathogenic mechanisms underlying their nephrotoxic effects. This knowledge is essential in order to mitigate the occurrence of renal injury.  A comprehensive understanding of risk factors linked to particular patient populations and specific drug classes, in conjunction with prompt identification, therapeutic drug monitoring with dosage modifications, and timely implementation of prospective interventions, are crucial for the prevention and improved management of these conditions. The majority of cases of drug-induced renal toxicity can be reversed if detected and treated promptly in the early stages, thereby preventing progression to end-stage renal failure. This study provides a comprehensive overview of various forms of renal failure, encompassing its diagnosis, therapy, risk factors, and preventive measures pertaining to drug-induced nephrotoxicity.

Abstract 133 | pdf Downloads 76

References

1. Sales GT, Foresto RD. Drug-induced nephrotoxicity. Revista da Associação Médica Brasileira. 2020 Jan 13;66: s82-90. https://doi.org/10.1590/1806-9282.66.S1.82
2. Kane-Gill SL, Goldstein SL. Drug-induced acute kidney injury: a focus on risk assessment for prevention. Critical care clinics. 2015 Oct 1;31(4):675-84.
https://doi.org/10.1016/j.ccc.2015.06.005
3. Wu H, Huang J. Drug-induced nephrotoxicity: pathogenic mechanisms, biomarkers and prevention strategies. Current drug metabolism. 2018 Jun 1;19(7):559-67.
https://doi.org/10.2174/1389200218666171108154419
4. Choudhury D, Ahmed Z. Drug-associated renal dysfunction and injury. Nature clinical practice Nephrology. 2006 Feb 1;2(2):80-91. https://doi.org/10.1038/ncpneph0076
5. Choudhury D, Ahmed Z. Drug-induced nephrotoxicity. Medical Clinics of North America. 1997 May 1;81(3):705-17. https://doi.org/10.1016/S0025-7125(05)70541-1
6. Wilcox CS. Metabolic and adverse effects of diuretics. InSeminars in nephrology 1999 Nov 1 (Vol. 19, No. 6, pp. 557-568). PMID: 10598543
7. Rose BD, Black RM. Manual of clinical problems in nephrology. (No Title). 1988.
8. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. New England Journal of Medicine. 1994 Dec 22;331(25):1675-9. https://doi.org/10.1056/NEJM199412223312502
9. Hropot M, Fowler N, Karlmark B, Giebisch G. Tubular action of diuretics: distal effects on electrolyte transport and acidification. Kidney international. 1985 Sep 1;28(3):477-89. https://doi.org/10.1038/ki.1985.154
10. Whitworth JA, Lawrence JR. Textbook of renal disease. (No Title). 1987.
11. Edwards OM, Huskisson EC, Taylor RT. Azotaemia aggravated by tetracycline. Br Med J. 1970 Jan 3;1(5687):26-7. https://doi.org/10.1136/bmj.1.5687.26
12. Huang J, Weinfurter S, Pinto PC, Pretze M, Kränzlin B, Pill J, Federica R, Perciaccante R, Ciana LD, Masereeuw R, Gretz N. Fluorescently labeled cyclodextrin derivatives as exogenous markers for real-time transcutaneous measurement of renal function. Bioconjugate Chemistry. 2016 Oct 19;27(10):2513-26. https://doi.org/10.1021/acs.bioconjchem.6b00452
13. Rahman M, Shad F, Smith MC. Acute kidney injury: a guide to diagnosis and management. American family physician. 2012 Oct 1;86(7):631-9. PMID: 23062091
14. Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Critical care. 2013 Feb; 17:1-5. https://doi.org/10.1186/cc11454
15. Murugan R, Kellum JA. Acute kidney injury: what's the prognosis? Nature Reviews Nephrology. 2011 Apr;7(4):209-17. https://doi.org/10.1038/nrneph.2011.13
16. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nature reviews Drug discovery. 2004 Aug 1;3(8):711-6. https://doi.org/10.1038/nrd1470
17. Fusco S, Garasto S, Corsonello A, Vena S, Mari V, Gareri P, Ruotolo G, Luciani F, Roncone A, Maggio M, Lattanzio F. Medication-induced nephrotoxicity in older patients. Current Drug Metabolism. 2016 Jul 1;17(6):608-25.
18. Philips BJ, Lane K, Dixon J, MacPhee I. The effects of acute renal failure on drug metabolism. Expert opinion on drug metabolism & toxicology. 2014 Jan 1;10(1):11-23.
https://doi.org/10.1517/17425255.2013.835802
19. Cox ZL, McCoy AB, Matheny ME, Bhave G, Peterson NB, Siew ED, Lewis J, Danciu I, Bian A, Shintani A, Ikizler TA. Adverse drug events during AKI and its recovery. Clinical journal of the American Society of Nephrology: CJASN. 2013 Jul 7;8(7):1070.
https://doi.org/10.2215%2FCJN.11921112
20. Perazella MA. Renal vulnerability to drug toxicity. Clinical Journal of the American Society of Nephrology. 2009 Jul 1;4(7):1275-83. https://doi.org/10.2215/CJN.02050309
21. Leblanc M, Kellum JA, Gibney RT, Lieberthal W, Tumlin J, Mehta R. Risk factors for acute renal failure: inherent and modifiable risks. Current opinion in critical care. 2005 Dec 1;11(6):533-6. https://doi.org/10.1097/01.ccx.0000183666.54717.3d
22. Schrier RW. Urinary indices and microscopy in sepsis-related acute renal failure. American journal of kidney diseases. 2006 Nov 1;48(5):838-41. https://doi.org/10.1053/j.ajkd.2006.08.024
23. Bellomo R. The epidemiology of acute renal failure: 1975 versus 2005. Current opinion in critical care. 2006 Dec 1;12(6):557-60. https://doi.org/10.1097/01.ccx.0000247443.86628.68
24. Naughton CA. Drug-induced nephrotoxicity. American family physician. 2008 Sep 15;78(6):743-50.
25. Perazella MA. Crystal-induced acute renal failure. The American journal of medicine. 1999 Apr 1;106(4):459-65. https://doi.org/10.1016/S0002-9343(99)00041-8